Genetic susceptibility to systemic lupus erythematosus in the genomic era (original) (raw)

• Deapen, D. et al. A revised estimate of twin concordance in SLE. Arthritis Rheum. 35, 311–318 (1992).
  Article CAS PubMed Google Scholar
• Alarcón-Segovia, D. et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 52, 1138–1147 (2005).
  Article PubMed Google Scholar
• Nath, S. K. et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat. Genet. 40, 152–154 (2008).
  Article CAS PubMed Google Scholar
• Hom, G. et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900–909 (2008).
  Article CAS Google Scholar
• Harley, J. B. et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204–210 (2008).
  Article CAS Google Scholar
• Kozyrev, S. V. et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40, 211–216 (2008).
  Article CAS PubMed Google Scholar
• Graham, R. R. et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40, 1059–1061 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228–1233 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Han, J. W. et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234–1237 (2009).
  Article CAS PubMed Google Scholar
• Yang, W. et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6, e1000841 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Moser, K. L., Kelly, J. A., Lessard, C. J. & Harley, J. B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 10, 373–379 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Harley, I. T., Kaufman, K. M., Langefeld, C. D., Harley, J. B. & Kelly, J. A. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat. Rev. Genet. 10, 285–290 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rhodes, B. & Vyse, T. J. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 47, 1603–1611 (2008).
  Article CAS Google Scholar
• Crow, M. K. Collaboration, genetic associations, and lupus erythematosus. N. Engl. J. Med. 358, 956–961 (2008).
  Article CAS PubMed Google Scholar
• Vyse, T. J. & Todd, J. A. Genetic analysis of autoimmune disease. Cell 85, 311–318 (1996).
  Article CAS PubMed Google Scholar
• Goldberg, M. A., Arnett, F. C., Bias, W. B. & Shulman, L. E. Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum. 19, 129–132 (1976).
  Article CAS PubMed Google Scholar
• The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 401, 921–923 (1999).
• Tsao, B. P. in Dubois' Lupus Erythematosus, 6th edn (eds Wallace, D. J. & Hahn, B. H.) 97–120 (Lippincott Williams & Wilkins, Philadelphia, 2002).
  Google Scholar
• Graham, R. R. et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71, 543–553 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Doherty, D. G. et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum. 35, 641–646 (1992).
  Article CAS PubMed Google Scholar
• Hong, G. H. et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J. Rheumatol. 21, 442–447 (1994).
  CAS PubMed Google Scholar
• Lee, H. S. et al. Independent association of HLA-DR and Fcγ receptor polymorphisms in Korean patients with systemic lupus erythematosus. Rheumatology (Oxford) 42, 1501–1507 (2003).
  Article CAS Google Scholar
• Jiang, C. et al. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J. Immunol. 184, 1085–1091 (2010).
  Article CAS PubMed Google Scholar
• Walport, M. J. Complement. Second of two parts. N. Engl. J. Med. 344, 1140–1144 (2001).
  Article CAS PubMed Google Scholar
• Wu, Y. L., Hauptmann, G., Viguier, M. & Yu, C. Y. Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun. 10, 433–445 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Truedsson, L., Bengtsson, A. A. & Sturfelt, G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 40, 560–566 (2007).
  Article CAS PubMed Google Scholar
• Schifferli, J. A., Steiger, G., Paccaud, J. P., Sjöholm, A. G. & Hauptmann, G. Difference in the biological properties of the two forms of the fourth component of human complement (C4). Clin. Exp. Immunol. 63, 473–477 (1986).
  CAS PubMed PubMed Central Google Scholar
• Blanchong, C. A. et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologs, Slp and C4. Int. Immunopharmacol. 1, 365–392 (2001).
  Article CAS PubMed Google Scholar
• Pickering, M. C. & Walport, M. J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 39, 133–141 (2000).
  Article CAS Google Scholar
• Yang, Y. et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am. J. Hum. Genet. 80, 1037–1054 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Fernando, M. M. et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet. 3, e192 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, Z., Shen, L., Dangel, A. W., Wu, L. C. & Yu, C. Y. Four ubiquitously expressed genes, _RD(D6S45)_–_SKI2W(SKIV2L)–_DOM3Z_–_RP1(D6S60E), are present between complement component genes factor B and C4 in the class III region of the HLA. Genomics 53, 338–347 (1998).
  Article CAS PubMed Google Scholar
• Barcellos, L. F. et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 5, e1000696 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Graham, R. R. et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38, 550–555 (2006).
  Article CAS PubMed Google Scholar
• Graham, R. R. et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl Acad. Sci. USA 104, 6758–6763 (2007).
  Article CAS PubMed Google Scholar
• Sigurdsson, S. et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet. 17, 872–881 (2008).
  Article CAS PubMed Google Scholar
• Demirci, F. Y. et al. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann. Hum. Genet. 71, 308–311 (2007).
  Article CAS PubMed Google Scholar
• Shin, H. D. et al. Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res. Ther. 9, R32 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kawasaki, A. et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum. 58, 826–834 (2008).
  Article CAS PubMed Google Scholar
• Siu, H. O. et al. Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. J. Rheumatol. 35, 360–362 (2008).
  CAS PubMed Google Scholar
• Kelly, J. A. et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun. 9, 187–194 (2008).
  Article CAS PubMed Google Scholar
• Löfgren, S. E. et al. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J. Rheumatol. 37, 574–578 (2010).
  Article CAS PubMed Google Scholar
• Niewold, T. B. et al. Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients. Arthritis Rheum. 58, 2481–2487 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Rullo, O. J. et al. Association of IRF5 polymorphisms with activation of the interferon-α pathway. Ann. Rheum. Dis. 69, 611–617 (2010).
  Article CAS PubMed Google Scholar
• Richez, C. et al. IFN regulatory factor 5 is required for disease development in the FcγRIIB−/−Yaa and FcγRIIB−/− mouse models of systemic lupus erythematosus. J. Immunol. 184, 796–806 (2010).
  Article CAS PubMed Google Scholar
• Remmers, E. F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357, 977–986 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Taylor, K. E. et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet. 4, e1000084 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Palomino-Morales, R. J. et al. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun. 9, 379–382 (2008).
  Article CAS PubMed Google Scholar
• Kawasaki, A. et al. Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1–STAT4 region. Arthritis Res. Ther. 10, R113 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sigurdsson, S. et al. A risk haplotype of STAT4 for systemic lupus erythematosus is overexpressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum. Mol. Genet. 17, 2868–2876 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kariuki, S. N. et al. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-α in lupus patients in vivo. J. Immunol. 182, 34–38 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Abelson, A. K. et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 68, 1746–1753 (2009).
  Article CAS PubMed Google Scholar
• Namjou, B. et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 60, 1085–1095 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, S., Dadi, H., Shaoul, E., Sharfe, N. & Roifman, C. M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93, 2013–2024 (1999).
  CAS PubMed Google Scholar
• Gregersen, P. K. & Olsson, L. M. Recent advances in the genetics of autoimmune disease. Annu. Rev. Immunol. 27, 363–391 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337–338 (2004).
  Article CAS PubMed Google Scholar
• Orrú, V. et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum. Mol. Genet. 18, 569–579 (2009).
  Article CAS PubMed Google Scholar
• Kariuki, S. N., Crow, M. K. & Niewold, T. B. The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-α activity and low tumor necrosis factor α levels in patients with lupus. Arthritis Rheum. 58, 2818–2823 (2008).
  Article PubMed PubMed Central Google Scholar
• Bredius, R. G. et al. Phagocytosis of Staphylococcus aureus and Hemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFcγ RIIa polymorphism to IgG2. J. Immunol. 151, 1463–1472 (1993).
  CAS PubMed Google Scholar
• Duits, A. J. et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 38, 1832–1836 (1995).
  Article CAS PubMed Google Scholar
• Yap, S. N., Phipps, M. E., Manivasagar, M., Tan, S. Y. & Bosco, J. J. Human Fcγ receptor IIA (FcγRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia. Lupus 8, 305–310 (1999).
  Article CAS PubMed Google Scholar
• Chen, J. Y. et al. Fcγ receptor IIa, IIIa, and IIIb polymorphisms of systemic lupus erythematosus in Taiwan. Ann. Rheum. Dis. 63, 877–880 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Salmon, J. E. et al. Fcγ RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97, 1348–1354 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Song, Y. W. et al. Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum. 41, 421–426 (1998).
  Article CAS PubMed Google Scholar
• Koene, H. R. et al. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum. 41, 1813–1818 (1998).
  Article CAS PubMed Google Scholar
• Alarcón, G. S. et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 3, e396 (2006).
  Article PubMed PubMed Central Google Scholar
• Zuniga, R. et al. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCγ receptor type IIA alleles. Arthritis Rheum. 48, 460–470 (2003).
  Article CAS PubMed Google Scholar
• Magnusson, V. et al. Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun. 5, 130–137 (2004).
  Article CAS PubMed Google Scholar
• Sullivan, K. E. et al. Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) 42, 446–452 (2003).
  Article CAS Google Scholar
• Kyogoku, C. et al. Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 46, 1242–1254 (2002).
  Article CAS PubMed Google Scholar
• Siriboonrit, U. et al. Association of Fcγ receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 61, 374–383 (2003).
  Article CAS PubMed Google Scholar
• Chu, Z. T. et al. Association of Fcγ receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63, 21–27 (2004).
  Article CAS PubMed Google Scholar
• Li, X. et al. A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48, 3242–3252 (2003).
  Article CAS PubMed Google Scholar
• Kyogoku, C., Tsuchiya, N., Wu, H., Tsao, B. P. & Tokunaga, K. Association of Fcγ receptor IIA, but not IIB and IIIA, polymorphisms with systemic lupus erythematosus: a family-based association study in Caucasians. Arthritis Rheum. 50, 671–673 (2004).
  Article CAS PubMed Google Scholar
• Magnusson, V. et al. Polymorphisms of the Fcγ receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis Rheum. 50, 1348–1350 (2004).
  Article CAS PubMed Google Scholar
• Floto, R. A. et al. Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11, 1056–1058 (2005).
  Article CAS PubMed Google Scholar
• Su, K. et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J. Immunol. 172, 7192–7199 (2004).
  Article CAS PubMed Google Scholar
• Salmon, J. E., Edberg, J. C. & Kimberly, R. P. Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest. 85, 1287–1295 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Hatta, Y. et al. Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun. 1, 53–60 (1999).
  Article CAS PubMed Google Scholar
• Clark, M. R., Liu, L., Clarkson, S. B., Ory, P. A. & Goldstein, I. M. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J. Clin. Invest. 86, 341–346 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Koene, H. R., Kleijer, M., Roos, D., de Hasse, M. & Von dem Borne, A. E. FcγRIIIB gene duplication: evidence for presence and expression of three distinct FcγRIIIB genes in NA(1+,2+)SH(+) individuals. Blood 91, 673–679 (1998).
  CAS PubMed Google Scholar
• Willcocks, L. C. et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J. Exp. Med. 205, 1573–1582 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Walport, M. J., Davies, K. A. & Botto, M. C1q and systemic lupus erythematosus. Immunobiology 199, 265–285 (1998).
  Article CAS PubMed Google Scholar
• Racila, D. M. et al. Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 12, 124–132 (2003).
  Article CAS PubMed Google Scholar
• Namjou, B. et al. Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun. 10, 517–524 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yamada, M. et al. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur. J. Immunol. 34, 221–230 (2004).
  Article CAS PubMed Google Scholar
• Lood, C. et al. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 60, 3081–3090 (2009).
  Article CAS PubMed Google Scholar
• Kollewe, C. et al. Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adaptor in interleukin-1 signaling. J. Biol. Chem. 279, 5227–5236 (2004).
  Article CAS PubMed Google Scholar
• Jacob, C. O. et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 106, 6256–6261 (2009).
  Article PubMed Google Scholar
• Sawalha, A. H. et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 3, e1727 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587–598 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3'–5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065–1067 (2007).
  Article CAS PubMed Google Scholar
• Ramantani, G. et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi–Goutières syndrome. Arthritis Rheum. 62, 1469–1477 (2010).
  Article CAS PubMed Google Scholar
• Ito, T. et al. OX40 ligand shuts down IL-10-producing regulatory T cells. Proc. Natl Acad. Sci. USA 103, 13138–13143 (2006).
  Article CAS PubMed Google Scholar
• Stüber, E., Neurath, M., Calderhead, D., Fell, H. P. & Strober, W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2, 507–521 (1995).
  Article PubMed Google Scholar
• Cunninghame Graham, D. S. et al. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat. Genet. 40, 83–89 (2008).
  Article CAS PubMed Google Scholar
• Delgado-Vega, A. M. et al. Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus. Genes Immun. 10, 248–253 (2009).
  Article CAS PubMed Google Scholar
• Hagiwara, E., Gourley, M. F., Lee, S. & Klinman, D. K. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum. 39, 379–385 (1996).
  Article CAS PubMed Google Scholar
• Eskdale, J. et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl Acad. Sci. USA 95, 9465–9470 (1998).
  Article CAS PubMed Google Scholar
• Eskdale, J., Wordsworth, P., Bowman, S., Field, M. & Gallagher, G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 49, 635–639 (1997).
  Article CAS PubMed Google Scholar
• Mehrian, R. et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to SLE. Arthritis Rheum. 41, 596–602 (1998).
  Article CAS PubMed Google Scholar
• Chong, W. P. et al. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun. 5, 484–492 (2004).
  Article CAS PubMed Google Scholar
• Bengtsson, A. A. et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9, 664–671 (2000).
  Article CAS PubMed Google Scholar
• Okamoto, T. NFκB and rheumatic diseases. Endocr. Metab. Immune Disord. Drug Targets 6, 359–372 (2006).
  Article CAS PubMed Google Scholar
• Beyaert, R., Heyninck, K. & Van Huffel, S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60, 1143–1151 (2000).
  Article CAS PubMed Google Scholar
• Shimane, K. et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum. 62, 574–579 (2010).
  Article CAS PubMed Google Scholar
• Salloum, R. et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 62, 553–561 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Reth, M. & Wienands, J. Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15, 453–479 (1997).
  Article CAS PubMed Google Scholar
• Zhang, Z. et al. The association of the BLK gene with SLE was replicated in Chinese Han. Arch. Dermatol. Res. 302, 619–624 (2010).
  Article CAS PubMed Google Scholar
• Ito, I. et al. Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. Arthritis Rheum. 60, 553–558 (2009).
  Article CAS PubMed Google Scholar
• Yokoyama, K. et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. EMBO J. 21, 83–92 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Maier, H., Colbert, J., Fitzsimmons, D., Clark, D. R. & Hagman, J. Activation of the early B-cell-specific mb-1 (Ig-α) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell. Biol. 23, 1946–1960 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Moisan, J., Grenningloh, R., Bettelli, E., Oukka, M. & Ho, I. C. Ets-1 is a negative regulator of TH17 differentiation. J. Exp. Med. 204, 2825–2835 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, D. et al. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int. Immunol. 17, 1179–1191 (2005).
  Article CAS PubMed Google Scholar
• Wojcik, H., Griffiths, E., Staggs, S., Hagman, J. & Winandy, S. Expression of a non-DNA-binding Ikaros isoform exclusively in B cells leads to autoimmunity but not leukemogenesis. Eur. J. Immunol. 37, 1022–1032 (2007).
  Article CAS PubMed Google Scholar
• Luo, B. H., Carman, C. V. & Springer, T. A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619–647 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Han, S. et al. Evaluation of imputation-based association in and around the integrin-αM (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum. Mol. Genet. 18, 1171–1180 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, W. et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet. 18, 2063–2070 (2009).
  Article CAS PubMed PubMed Central Google Scholar